BeiGene Stock Rockets On Collaboration Deal With Biotech Company Amgen – Investor’s Business Daily

BeiGene stock rocketed late Thursday after the biotech company announced a collaboration deal that will have Amgen (AMGN) take a $2.7 billion stake in it.
XIn after-hours trading on the stock market today, shares of BeiGene (BGNE) launched 25.5%, near 173. A…

Click here to view the original article.